logo
logo

Sun Pharma acquires Checkpoint Therapeutics, Inc.

May 30, 2025•2 months ago

Acquiring Company

Sun Pharma

Acquired Company

Checkpoint Therapeutics

MumbaiWalthamHealth CareBiotechnologyManufacturing

Description

Sun Pharmaceutical Industries has successfully completed its acquisition of Checkpoint Therapeutics, valued at $355 million. This acquisition includes the FDA-approved UNLOXCYTTM treatment for skin cancer. By acquiring Checkpoint, Sun Pharma aims to enhance its innovative therapies and expand its oncology product offerings. The merger follows a shareholder lawsuit alleging conflicts of interest.

Company Information

Company

Sun Pharma

Location

Mumbai, Maharashtra, India

About

Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients primarily in India and the United States.

Related People

Sign in to view contact details

Sign in to view contact details

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed